Iris-claw phakic intraocular lens for high myopia

J Refract Surg. 2001 Nov-Dec;17(6):634-40. doi: 10.3928/1081-597X-20011101-01.

Abstract

Purpose: To evaluate the efficacy, safety, predictability, and stability of implanting a polymethylmethacrylate (PMMA) phakic intraocular lens (PIOL) (the Artisan myopia lens) to correct high myopia.

Methods: An Artisan myopia lens was implanted in 78 consecutive eyes of 49 patients with preoperative myopia that ranged from -6.25 to -28.00 D. Mean patient age was 42.4 years. Mean follow-up was 10.7 months and all patients were followed for at least 6 months; 45 eyes had follow-up of 12 months, and 10 eyes had 24 months. The desired outcome was emmetropia in all eyes except for those eyes with preoperative myopia greater then -23.00 D.

Results: Fifty-three eyes (67.9%) had a postoperative refraction at the last follow-up examination within +/-1.00 D of emmetropia, and 39 eyes (50.0%) had a postoperative refraction +/- within 0.50 D of emmetropia. The postoperative refraction remained stable during the entire follow-up period. Mean spectacle-corrected visual acuity improved from 20/32 preoperatively to 20/25 postoperatively. Mean postoperative uncorrected visual acuity was 20/32. There was no significant change in endothelial cell density from baseline. We did not encounter major complications.

Conclusion: Implantation of the Artisan myopia lens to correct high myopia resulted in a stable and fairly predictable refractive outcome. A significant endothelial cell change was not detected.

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Humans
  • Iris / surgery*
  • Lens Implantation, Intraocular*
  • Lens, Crystalline / physiology*
  • Lenses, Intraocular
  • Male
  • Middle Aged
  • Myopia / physiopathology
  • Myopia / surgery*
  • Polymethyl Methacrylate
  • Refraction, Ocular
  • Safety
  • Treatment Outcome
  • Visual Acuity

Substances

  • Polymethyl Methacrylate